The NHS Genomic Medicine Service has precipitated a sharp increase in the volume and diversity of referrals for cancer-gene sequencing.

The cancer test directory informs a list of essential and investigational genes which can be targeted to maximize clinical insight.

Dr Patrick Tarpey presents an overview of large NGS panel screening from a clinical perspective, illuminating the value of permissive analysis and the necessity for a singular DSS solution to enable rapid exploration of all variant classes in a myriad of different cancer types.

Fill Out Form to Access Webinar

Your email address is never shared with third parties.

Date & Time
25 Apr 2024
Cambridge University Hospitals NHS Foundation Trust
Dr Patrick Tarpey, Lead Clinical Scientist in Cancer Genetics
Oncology, Cancer research
Watch Now